PMID- 22125457 OWN - NLM STAT- MEDLINE DCOM- 20120327 LR - 20211021 IS - 1537-744X (Electronic) IS - 2356-6140 (Print) IS - 1537-744X (Linking) VI - 11 DP - 2011 TI - Overlapping, additive and counterregulatory effects of type II and I interferons on myeloid dendritic cell functions. PG - 2071-90 LID - 10.1100/2011/873895 [doi] AB - Dendritic cells (DCs) are central player in immunity by bridging the innate and adaptive arms of the immune system (IS). Interferons (IFNs) are one of the most important factors that regulate both innate and adaptive immunity too. Thus, the understanding of how type II and I IFNs modulate the immune-regulatory properties of DCs is a central issue in immunology. In this paper, we will address this point in the light of the most recent literature, also highlighting the controversial data reported in the field. According to the wide literature available, type II as well as type I IFNs appear, at the same time, to collaborate, to induce additive effects or overlapping functions, as well as to counterregulate each one's effects on DC biology and, in general, the immune response. The knowledge of these effects has important therapeutic implications in the treatment of infectious/autoimmune diseases and cancer and indicates strategies for using IFNs as vaccine adjuvants and in DC-based immune therapeutic approaches. FAU - Frasca, Loredana AU - Frasca L AD - Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanita, 00161 Rome, Italy. lfrasca@iss.it FAU - Lande, Roberto AU - Lande R LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20111101 PL - United States TA - ScientificWorldJournal JT - TheScientificWorldJournal JID - 101131163 RN - 0 (Interferon Type I) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Dendritic Cells/*immunology MH - Humans MH - Interferon Type I/*physiology MH - Interferon-gamma/*physiology MH - Myeloid Cells/*immunology PMC - PMC3221594 OTO - NOTNLM OT - IFNs OT - cross-regulation OT - dendritic cell effector functions OT - immune activation OT - immune regulation EDAT- 2011/11/30 06:00 MHDA- 2012/03/28 06:00 PMCR- 2011/11/01 CRDT- 2011/11/30 06:00 PHST- 2011/04/08 00:00 [received] PHST- 2011/09/27 00:00 [accepted] PHST- 2011/11/30 06:00 [entrez] PHST- 2011/11/30 06:00 [pubmed] PHST- 2012/03/28 06:00 [medline] PHST- 2011/11/01 00:00 [pmc-release] AID - 10.1100/2011/873895 [doi] PST - ppublish SO - ScientificWorldJournal. 2011;11:2071-90. doi: 10.1100/2011/873895. Epub 2011 Nov 1.